Victory Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,608
Closed -$548K 2773
2022
Q3
$548K Sell
10,608
-3,469
-25% -$143K ﹤0.01% 2010
2022
Q2
$349K Buy
14,077
+981
+7% +$21.6K ﹤0.01% 2192
2022
Q1
$242K Buy
13,096
+6,372
+95% +$179K ﹤0.01% 2365
2021
Q4
$245K Buy
+6,724
New +$236K ﹤0.01% 2435
2021
Q2
Sell
-10,392
Closed -$532K 2831
2021
Q1
$532K Sell
10,392
-3,729
-26% -$224K ﹤0.01% 2178
2020
Q4
$874K Buy
14,121
+649
+5% +$37.2K ﹤0.01% 1844
2020
Q3
$738K Buy
13,472
+804
+6% +$43.3K ﹤0.01% 1830
2020
Q2
$729K Sell
12,668
-4,094
-24% -$223K ﹤0.01% 1864
2020
Q1
$674K Buy
16,762
+6,848
+69% +$291K ﹤0.01% 1991
2019
Q4
$392K Buy
9,914
+3,120
+46% +$54.8K ﹤0.01% 2112
2019
Q3
$46K Buy
+6,794
New +$51K ﹤0.01% 2728

Other funds holding CCXI

Victory Capital Management's CCXI Position: Q4 2022 in Review

Victory Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 10,608 shares — an estimated $548K sold.

Victory Capital Management first reported a position in CCXI in Q3 2019 and held it in 11 quarters. The position peaked at $874K in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Victory Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 10,608 ChemoCentryx, Inc. shares in Q4 2022, an estimated $548K.
  • Victory Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2019 and held it in 11 quarters.
  • Victory Capital Management's ChemoCentryx, Inc. position peaked at $874K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.